its a neutral report they beat estimates part of that stemming from poor guidence from last qtr,would like to hear from mgt.at best this is a pretty little event,there simply is no compelling reason,product that would get me to add new money nor do i see avg investors looking at this,of course depending on mgt comments this could change
The financials don't matter at this point - they hired a CEO that is suppose to be connected to the phram industry and it means nothing. They should look at the business as tech business not an ad based business. Yahoo is taking that approach and it makes sense.
They hired the wrong CEO.